NewGenIvf Group Limited
NIVF
$0.63
$0.034.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 435.03% | -443.72% | 89.96% | 0.00% |
| Total Depreciation and Amortization | 0.00% | -103.39% | 1,834.41% | 9.41% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 99.20% | -1,568.57% | -338.64% | 0.00% |
| Change in Net Operating Assets | 0.00% | 85.53% | 18.52% | -397.13% | 0.00% |
| Cash from Operations | 0.00% | 92.08% | 17.26% | -424.30% | 0.00% |
| Capital Expenditure | 0.00% | -1,077.78% | 93.23% | -667.31% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -22,902.44% | 207.19% | -2,960.00% | 0.00% |
| Cash from Investing | 0.00% | -27,628.47% | 124.77% | -870.18% | 0.00% |
| Total Debt Issued | 0.00% | -18.76% | 704.63% | -151.80% | 0.00% |
| Total Debt Repaid | -- | -- | 200.00% | -3,909.38% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 93.96% | -106.49% | 300.00% | 0.00% |
| Cash from Financing | 0.00% | -15.43% | -17.49% | 427.98% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | -683.80% | 111.81% | -291.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 99.72% | 2,100.69% | -122.15% | 0.00% |